金年会金字招牌信誉至上

News Company News
Pantoprazole Passed the Consistency Evaluation to RLD
    Friday 30th of April 2021 10:37:34 AM
On January 18, 2021,  Baiyu received the notice issued by NMPA(National Medical Products Administration), saying that Baiyu's Pantoprazole Sodium injection has officially passed the Consistency Evaluation, which means NMPA has accredited that Baiyu's Pantoprazole Sodium injection has the same or even better quality and efficacy compared to Reference Listed Drug.
XML 地图